Ascend Capital’s Acacia Research ACTG Stock Holding History

Ascend Capital’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-40,145	Closed	-$897K	–	197
2013 Q2	$897K	Buy	+40,145	New	+$1.01M	0.04%	161

Other funds holding ACTG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

NRC

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

CPIM

Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return

Ascend Capital's ACTG Position: Q3 2013 in Review

Ascend Capital sold out of Acacia Research (ACTG) in Q3 2013, closing a stake of 40,145 shares — an estimated $897K sold.

Ascend Capital first reported a position in ACTG in Q2 2013 and held it in 1 quarter. The position peaked at $897K in Q2 2013. 125 funds tracked by Wall St. Rank hold ACTG as of Q3 2013.

Ascend Capital reported no remaining Acacia Research position as of Q3 2013 after selling out during the quarter.
Ascend Capital sold 40,145 Acacia Research shares in Q3 2013, an estimated $897K.
Ascend Capital first reported a position in Acacia Research in Q2 2013 and held it in 1 quarter.
Ascend Capital's Acacia Research position peaked at $897K in Q2 2013.
125 funds tracked by Wall St. Rank held Acacia Research as of Q3 2013.

Based on Ascend Capital's 13F filing for Q3 2013, filed 13 Nov 2013.